NCT06131840 2026-04-07A Study of SGN-CEACAM5C in Adults With Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting914 enrolled
NCT03221400 2022-02-17PEN-866 in Patients With Advanced Solid MalignanciesTarveda TherapeuticsPhase 1/2 Unknown340 enrolled
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled